Matt Stuckert Email & Phone Number

Philadelphia, Pa, Us

Jacksonville, Florida, Us

Report directly to CEO. Sales, marketing, and commercial leadership with cross-functional responsibilities through all phases of revenue generation, market development, product launch, customer experience and operations.

Jacksonville, Florida, Us

Seattle, Washington, Us

Seattle, Washington, Us

Venture-backed startup introducing a new product category with the first-to-market Steripath® Initial Specimen Diversion Device (ISDD)® designed to eliminate blood culture contamination and improve sepsis-testing accuracy. Hired in 2017 to build a national sales team and develop the US market for ISDD.Magnolia’s flagship commercial product, Steripath Initial Specimen Diversion Device®, is the only FDA-cleared device indicated to reduce blood culture contamination which causes false positive sepsis test results. Magnolia has designed a wide range of products to significantly improve diagnostic specimen quality aimed at directly and dramatically increasing diagnostic accuracy for critical laboratory tests. The company’s intellectual property portfolio includes more than 70 issued patents with more than 50 additional patent applications pending. As a company we are focused on establishing a new standard for sepsis testing accuracy to drive antibiotic stewardship, improve patient safety, impact key quality outcomes and significantly reduce healthcare costs. www.magnolia-medical.com• Report directly to Chief Commercial Officer. Sales and commercial leadership with cross-functional responsibilities through all phases of revenue generation, market development, product launch, customer experience and operations. Grew revenue 11x and customer base by 21x, at an average growth over prior year of 68%.

Fayetteville, Arkansas, Us

Venture-backed startup introducing a new product category with the first-to-market SafeBreak force-activated IV safety disconnection device, designed to safely separate catheter infusion lines and avoid dislodgement.• Provide sales, marketing, and strategic advice directly to the CEO to support commercialization of the innovative SafeBreak device in US hospital and veterinary markets.

Hayward, California, Us

Venture-backed startup and inventors of the SilvaClean silver-ion antimicrobial technology for textiles. Applied Silver is focused on Infection Prevention and Quality Improvement in the healthcare environment and beyond. Incorporated in 2012, Applied Silver is based in the San Francisco Bay Area, and formed as an entrepreneurial effort alongside California Polytechnic State University in San Luis Obispo, California. Applied's anchor innovation is a cost-effective, EPA-approved, water-based silver-ion textile treatment called SilvaClean®. It is a safe, yet powerful antimicrobial treatment that is applied each time textiles are laundered and works to prevent the growth of bacteria on products to which it is applied.• Report directly to CEO. New business development, sales, marketing, KOL development, and strategy for SilvaClean silver-ion antimicrobial technology to treat hospital textiles and soft surfaces.

Franklin Lakes, New Jersey, Us

Becton Dickinson acquired CareFusion in 2014 for $12.2B.• #1 ranked DCA - Contracted, managed and grew business across seven consumable businesses units covering infusion, respiratory, anesthesia, antiseptic skin prep, surgical instrumentation, minimally invasive surgery, chemotherapy, vertebral augmentation, drainage, and other disposables. Coordinate customer relationships across seven business units and sales teams. • Revenue responsibilities across twenty-one strategic customers including MSS, Ascension, BJC, SSM, ROi, Mercy, Northwestern, Aurora, OSF, and Univ of Chicago.

San Diego, Ca, Us

Spin-off publicly traded medical device company from Cardinal Health in July 2009. Carefusion was acquired by BD in 2014. • VP of the Year - Led multiple sales teams supporting four CareFusion business units: Vascular & Surgical Skin Preparation, Surgical Instrumentation, and Infusion Specialty Disposables. Revenue responsibilities up to $400M.• Launched multiple new products including StartClean preoperative bathing system, Surgicept waterless hand scrub, MaxPlus and MaxZero needleless connectors, Texium chemo safety system, and Snowden Pencer take-apart laparoscopic instruments.• Management oversight of the Eastern US with 60+ direct/indirect reports consisting of 6 Region Managers, 3 Directors of Corp Accts, 1 National Field Sales Trainer, 6 Clinical Educators, and 50 Sales Representatives split into two sales teams (Vascular and Surgical).• Supported the creation of the national US Corporate Accounts Team.• Initiated the creation of a country-wide direct sales team in Canada.

Dublin, Oh, Us

Cardinal Health acquired Enturia in May 2008. Cardinal Health spun off a new publicly traded stand-alone company, CareFusion, in July 2009.• VP of the Year, Manager of the Year, #1 ranked Region - Managed the Eastern US sales team supporting the Vascular & Surgical Skin Antiseptic portfolio.

Formerly Medi-Flex, Inc. - small family-run business launching the disruptive ChloraPrep antiseptic line to US hospitals in 2001. ChloraPrep was adopted by 80% of US hospitals over a seven-year timeframe. Enturia was acquired by Cardinal Health in 2008 for $490M.• District Manager of the Year, President’s Club, District Sales Excellence Award - Instrumental in building the US sales team and launching the ChloraPrep line of CHG-based skin antiseptics, growing to over $250M in domestic sales.

Venture-backed startup - acquired by CR Bard. Start-up member of the sales and management team introducing first-to-market StatLock catheter securement devices as an innovative technology in the vascular space.• #1 ranked Territory Manager, Region Sales Manager, and Distribution Manager supporting the first-to-market launch of StatLock. Promoted from sales team to first created Region Manager position.

Bs, Environmental Resource Management

Effective Sales Management

Finance & Accounting

Education record